协议和统计分析计划,用于血栓压素的毒冲击实证 (VASSPR) 集群交叉随机试验

Ithan D Peltan¹, Danielle Groat¹, Jason R Jacobs¹+20

• ¹Department of Pulmonary and Critical Care Medicine (I. D. P., D. G., J. R. J., E. H. T., S. J. B., J. H. E., N. A., E. L. H., J. R. C., M. J. L., C. K., C. K. G., S. M. B., and L. M. L.), the Department of Pharmacy (S. C. and H. S.), the Department of Emergency Medicine (J. R. B. and T. D. M. T.), Intermountain Medical Center, Murray, the Division of Epidemiology (B. J. B.), Department of Medicine, University of Utah; the Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine (E. L. H., C. K. G., and S. M. B.), Department of Medicine, University of Utah School of Medicine; Digital Technology Services (H. S., P. H., and T. D. M. T.), Intermountain Health, Salt Lake City; the Department of Emergency Medicine (A. T. S.), Park City Hospital, Park City, UT; the Division of Allergy, Pulmonary and Critical Care Medicine (M. W. S. and J. W. C.), Department of Medicine, and the Vanderbilt Institute for Clinical and Translational Research (M. W. S. and J. W. C.), Vanderbilt University Medical Center, Nashville, TN.